Revolo Biotherapeutics to Present at Upcoming Medical Meetings in May
GAITHERSBURG, MD and CAMBRIDGE, UK, May 14, 2024 – Revolo Biotherapeutics (“Revolo” or the “Company”), a company developing therapies that reset the immune system to achieve superior remission for patients with autoimmune and allergic diseases, today announced that it will present at two medical meetings in May: The American Thoracic Society (ATS) 2024 International Conference and […]
Revolo Biotherapeutics to Present at Upcoming Medical Meetings in May Read More »